Growing evidence has demonstrated that low-dose radiation can target inflammation and reduce pain for osteoarthritis patients ...
Embecta has agreed to acquire Owen Mumford Holdings for up to $172.6m, enhancing its global presence in drug delivery ...
LivaNova's aura6000 system delivers synchronised electrical pulses to the hypoglossal nerve to prevent airways collapse in OSA patients during sleep.
The FDA PMA for JenaValve's Trilogy device for TAVR-AR comes months after a court struck down Edwards Lifesciences attempt to ...
KORU Medical has received the EU MDR certification for its Freedom60 infusion pump, including an adapter compatible with 50ml ...
Nia Therapeutics' Smart Neurostimulation System (SNS) is the first device to obtain FDA breakthrough designation for memory ...
In data supporting FDA approval, 48.1% implanted with Prodeon’s Urocross saw International Prostate Symptom Score ...
Paradromics initiative establishes alliances with leading BCI researchers at institutions including Stanford University with ...
Neuracle Technology has received marketing approval from China’s NMPA) for its invasive brain-computer interface (BCI) device ...
Security experts highlight that Iran-linked hacktivist group Handala’s attack on Stryker reveals exposures within organisations endpoint management systems.
Boston Scientific is taking clear steps to advance its European, Middle East and Africa (EMEA) region market position in the urology space. The company drew significant attention ...
EPRs play a central role in the digital strategy of all NHS trusts, and as such, a lot of attention is paid to picking the correct partner for this critical digital infrastructure.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results